Alfred Yellson

Doctor of Medicine,  Cleveland Clinic 

Location: United States

Consulting Services

Scientific Writing Journal Manuscript IT-Web-Mobile Technology Hospital-Pharmacy-Insurance

Areas Of Interest

Bechterew's Disease PMP35 Pain, Obstetric System, Lateral Line Chromosomes, Group E Presynaptic Terminals Posttranslational Modification Choreoathetosis Self Mutilation Syndrome Corticosteroid Receptor Retinaldehyde Dehydrogenase G CSF Receptors Methenamine Trypsin Inhibitor Kunitz Soybean CTLA4-Ig Immunoconjugate Cetil von ct Tremors, Resting Stenosis, Coronary Artery Dwarfism Reticulata, Substantia Nigra Agents, Urological Antigens, CD Sphingosine 1 Phosphate Receptor 5 Dehydrogenase, Lipoyl Protein Phosphatase 2C delta

Professional Narrative

Dr. Alfred Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Harvard Med 2008
Senior Director, Harvard Med 1996

Education

Doctor of osteopathic medicine, Baylor College 1989
Doctor of osteopathic medicine, Perelman School of Medicine 1999

Referees


Publications

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :